Fexofenadine/Naproxen

้ž็ดข้ž้‚ฃๅฎš/่˜ๆ™ฎ็”Ÿ

Report date: 2022/09/06 17:03:40

Base Information

Drug NameFexofenadine/Naproxen
Drug Alias Name่˜ๆ™ฎ็”Ÿ+้ž็ดข้ž้‚ฃๅฎšNaproxen and Fexofenadine่˜ๆ™ฎ็”Ÿ/้ž็ดข้ž้‚ฃๅฎšFexofenadine and Naproxen้ž็ดข้ž้‚ฃๅฎš+่˜ๆ™ฎ็”Ÿ +[10]ย 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsCyclooxygenases inhibitors
TargetsHistamine H1 receptorCyclooxygenases
Therapy Area/IndicationsAlcohol-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes NaproxenFexofenadine Hydrochloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJmi Capital Group Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSen-Jam Pharmaceutical Llc
Active IndicationsN/A
Inactive IndicationsAlcohol-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A